Correlation between nonalcoholic fatty liver disease and coronary atherosclerosis

H Vu1, T T Khanh Tuong2, N Hoang Lan1

  • 1Department of Internal Medicine, School of Medicine, Viet Nam National University Ho Chi Minh City, Vietnam.

La Clinica Terapeutica
|November 14, 2022
PubMed

Insights

Nonalcoholic fatty liver disease (NAFLD) was not strongly linked to coronary atherosclerosis in a Vietnamese study. Further research with larger patient groups is needed to confirm any potential association between these conditions.

Area of Science:

  • Cardiology
  • Hepatology
  • Radiology

Background:

  • Coronary artery disease and fatty liver disease are prevalent global health concerns.
  • Non-invasive imaging modalities like coronary computed tomography angiography (CCTA) aid in assessing disease severity.
  • The correlation between hepatic steatosis and coronary atherosclerosis remains understudied, particularly in Vietnam.

Purpose of the Study:

  • To investigate the association between nonalcoholic fatty liver disease (NAFLD) and coronary atherosclerosis.
  • To evaluate the prevalence of NAFLD and coronary atherosclerosis in a Vietnamese patient cohort.

Main Methods:

  • An analytical cross-sectional study was conducted.
  • 223 patients from cardiology departments at Thong Nhat Hospital were included.
  • Coronary computed tomography angiography (CCTA) was used for assessment.

Main Results:

  • NAFLD was detected in 66% of the 223 patients.
  • The mean coronary artery stenosis (CAS) was 44.54% ± 20.23%.
  • No significant difference in significant atherosclerotic plaque or coronary artery calcification was observed between patients with and without NAFLD.

Conclusions:

  • NAFLD showed no strong association with coronary atherosclerosis in this study cohort.
  • Larger sample sizes are required to definitively establish any correlation.
  • Further research is warranted to explore the relationship between NAFLD and cardiovascular disease.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
37
Correlation01:09

Correlation

In statistics, two variables are said to be correlated if the values of one variable are associated with the other variable. Depending on the relationship between two variables, correlation can be of three types– positive correlation, negative correlation, and zero correlation.
Two variables, for example, a and b, are said to be positively correlated if both variables move in the same direction. In other words, a positive correlation exists between two variables, a and b, if:
12.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19